What Doctors and Patients Should Know About GLP-1 Drugs . Harvard Medicine Magazine
Achieving optimal health requires a solid foundation, especially when you begin a GLP-1 regimen
These topical approaches can be used alongside systemic medications or as standalone treatments for localized allodynia
Kadowaki T, Chin R, Ozeki A, Imaoka T, Ogawa Y
ATLANTA, June 29, 2026 /PRNewswire/ As digital health, telepsychiatry, and AI-driven mental healthcare rapidly expand, a foundational gap remains [...] To view or add a comment, sign in Kaiser Permanente researchers, pediatricians, and patients contribute to a major study exploring the best ways to treat anxiety in children and teens
J Endocrinol 264(2):e240210 McIntyre RS, Mansur RB, Rosenblat JD, Rhee TG, Cao B, Teopiz KM, Wong S, Le GH, Ho R, Kwan ATH (2025) Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: A replication study using reports to the World Health Organization pharmacovigilance database (VigiBase)